However, not all studies show a clear association between HDL-cholesterol and cardiovascular disease. 4,5 The observation that the capacity of serum to promote macrophage
T he well-established inverse relationship between high-density lipoprotein (HDL) cholesterol levels and cardiovascular disease in many human and animal studies suggests that HDL is protective against atherosclerosis. HDL has many biological activities that may contribute, including antioxidative and anti-inflammatory properties, but a major protective function is its central role in transport of cholesterol from peripheral tissues to the liver for biliary excretion. This reverse cholesterol transport pathway is thought to be important for the removal of excess cholesterol from foam cell macrophages in the artery wall, thereby limiting the development of atherosclerotic lesions. 1 Consistent with this, infusion of reconstituted HDL (rHDL) particles or overexpression of apolipoprotein A-I (apoA-I) promotes bile acid excretion and a reduction in plaque lipid content and lesion regression. 2, 3 cholesterol efflux is negatively correlated with intima-media thickness independently of HDL-cholesterol concentration suggests that HDL function may be a more accurate predictor of cardiovascular risk. 6, 7 HDL is a heterogeneous population of particles with a range of sizes and molecular compositions. 1 Differences in the functional activities of different HDL subfractions, particularly in removal of cellular cholesterol, may explain why static measures of HDL-cholesterol and cardiovascular risk do not always correlate well. 7 There is a significant current interest in the development of new therapies to increase HDL levels as a strategy for enhancing its cardioprotective functions although to date their success has been limited. 7 More detailed understanding of the subtleties of HDL particle heterogeneity and functional activity will facilitate the development of HDL-based therapies. The aim of the work reported here was to determine which HDL particle subfractions are most efficient in mediating cholesterol efflux from foam cell macrophages and to define the cholesterol transporter(s) involved in this process.
Two membrane transporters are most implicated in cholesterol export from macrophages. ATP-binding cassette transporter A1 (ABCA1) exports cholesterol to lipid-free apoA-I, 8 whereas ATP-binding cassette transporter G1 (ABCG1) mediates cholesterol efflux to mature HDL, but not to lipid-free apoA-I. 9 It has been suggested that ABCA1 mediates initial transfer of phospholipid and cholesterol to lipid-free/lipidpoor apoA-I, whereas ABCG1 mediates subsequent continued cholesterol export to these nascent HDL particles. Consistent with this mechanism, ABCA1 and ABCG1 can function cooperatively to remove cholesterol from cells in vitro 10 and combined deletion of ABCA1 and ABCG1 in mouse macrophages ablates cholesterol export to both apoA-I and HDL, impairs reverse cholesterol transport 11 and massively increases macrophage cholesterol accumulation in vivo. 12 However, the process may be more complex. Some studies suggest that ABCA1 exports cholesterol not only to lipid-free apoA-I, but also to HDL. 8, [12] [13] [14] [15] [16] [17] [18] Furthermore, cholesterol export to HDL from mouse macrophages is more severely inhibited by deletion of ABCA1 than that of ABCG1 (≈70% versus 30% inhibition 12 ), whereas deletion of ABCG1 in human macrophages does not inhibit cholesterol export to HDL. 18 This suggests that ABCA1 is a major mediator of cholesterol export to HDL and to lipid-free/poor apoA-I although it is unclear which HDL subfractions are most efficient acceptors.
To measure the relative efficiencies of different HDL particles in cholesterol efflux and the transporters involved, we used rHDL particles of defined size and composition, isolated subfractions of plasma HDL, cell lines expressing ABCA1 or ABCG1, and macrophages in which ABCA1 or ABCG1 expression was deleted. We confirm that ABCA1 is a major mediator of macrophage cholesterol efflux to HDL, whereas ABCG1 has a minor or negligible role in this process. Furthermore, we demonstrate that ABCA1-mediated cholesterol efflux is most efficient with small, dense HDL3b and HDL3c, suggesting that strategies that raise the levels and improve cholesterol efflux capacity of these species in vivo may be more antiatherogenic than those that favor elevation of large HDL species, as we previously proposed.
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Methods
Detailed Methods are available in the Online Data Supplement.
Cells
The study used Chinese hamster ovary (CHO) cells stably expressing human ABCA1 or ABCG1, bone-marrow macrophages isolated from wild-type, ABCA1-null, and ABCG1-null mice (all on a C57/Bl6 background), human THP-1 macrophage-like cells in which ABCA1 or ABCG1 was stably silenced and human monocyte-derived macrophages from normal and Tangier disease subjects. Full details of these cells and their cultures are provided in the Online Data Supplement.
Cholesterol Efflux
Briefly, cells were preloaded for 24 hours with [
3 H]-cholesterol±acetylated low-density lipoprotein (where specified), then washed and equilibrated for 1 hour in serum-free medium, followed by incubation with the indicated HDL species or lipid-free apoA-I in serum-free medium supplemented with bovine serum albumin (0.1% wt/vol), usually for 6 hours. Efflux was routinely measured as the percentage of [ 
Results
Cholesterol Efflux From ABCA1-CHO and ABCG1-CHO Cells
We first surveyed the capacity of ABCA1 and ABCG1 to export cholesterol to a range of acceptors, using CHO cells stably expressing human ABCA1 or human ABCG1 (Figure 1 ). 10, 18 Endogenous expression of ABCA1 or ABCG1 is undetectable in these cells, and stable overexpression of either transporter has no effect on endogenous expression of the complementary transporter (data not shown). ABCA1-or ABCG1-specific cholesterol efflux (Figure 1) is the difference between the rates of cholesterol efflux from cells overexpressing the transporter and matched control cells. As expected, ABCA1 exported cholesterol most efficiently to lipid-free apoA-I ( Figure 1A , closed circles), with a K m of 0.64±0.15 g/mL, similar to other studies. 13, 20, 21 Notably, ABCA1 also mediated substantial efflux of cholesterol to HDL3 and, less efficiently, to HDL2 ( Figure 1) .
Consistent with earlier studies, ABCG1 mediated cholesterol efflux most efficiently to HDL2 and HDL3 but little to lipid-free apoA-I ( Figure 1B) . 10, 22 We further studied ABCG1-specific efflux to a broader range of acceptors (Table) . Discoidal rHDL were the most efficient acceptor at matched protein concentrations, whereas the efficiency order was HDL3>HDL2>discoidal rHDL>SUV>spherical rHDL at matched phospholipid concentration,. ABCG1 exported cholesterol equally efficiently to spherical rHDL generated with many different apolipoproteins ( Figure 1C ; composition in Online Table I ). 
Nonstandard Abbreviations and Acronyms
ABCA1-and ABCG1-Specific Cholesterol Efflux to rHDLs of Defined Size
To further characterize the acceptor specificity of ABCA1 and ABCG1, we used rHDL particles of defined composition and particle size. Although these particles lack many of the proteins normally associated with plasma HDL fractions, such rHDL species are similar structurally and functionally to the discoidal HDL secreted by the liver, including their ability to activate LCAT (lecithin-cholesterol acyltransferase), 23 stimulate cholesterol efflux, 13 and inhibit inflammation. 24 Discoidal rHDL preparations generated using fixed ratios of phospholipid and apoA-I contain a mixture of discrete particles, which were separated by gel exclusion chromatography 13 (Online Figure I ), allowing us to examine the effect of particle size on cholesterol efflux activity. The abilities of several purified discoidal rHDLs (diameters, 7.5-11.9 nm; representative of plasma HDL particle diameters) 1 to mediate ABCA1-and ABCG1-dependent cholesterol efflux were compared.
When presented at matched protein concentrations, ABCA1-specific cholesterol efflux to the smallest (7.5 nm) rHDL was efficient, similar to lipid-free apoA-I, whereas the larger particles (11.9, 10.9, and 8.7 nm) were much less effective ( Figure 2A) . A similar efflux efficiency ranking was observed when the particles normalized on phospholipid concentration ( Figure 2B ). Figure 2C and 2D presents data combined from 3 separate discoidal rHDL preparations. To allow for slight variations in cellular efflux activity between experiments, all ABCA1-specific efflux data are expressed as a percentage of efflux to lipid-free apoA-I measured in the same experiment. Particles below a threshold diameter of ≈8.0 nm and a phospholipid:apoA-I molar ratio of ≈50:1 stimulated markedly increased ABCA1-dependent cholesterol efflux, relative to larger particles.
To determine whether there was a detectable change in the apoA-I content or conformation in rHDLs around this threshold, we further examined the structure of purified discoidal rHDLs (7.6-9.2 nm; Online Figure II ). Crosslinking analysis established that all particles contained 2 molecules of apoA-I (Online Figure  IIB) . Study of the organization of apoA-I in the discoidal rHDL by surface plasmon resonance analysis 25 (Online Figure IIC) indicated that almost all of the apoA-I epitopes probed, with the exception of C-terminal residues 222 to 242, were significantly *rHDL disc preparations contained apoA-I:PL ratios of 1:70 to 1:99 and a range of particle sizes from 9.5 to 13.1 nm.
†rHDL spheres contained molar ratios of apoA-I:PL:CE:UC=1:65:14.6:3.8 (9.5 nm diameter).
ABCA1 indicates ATP binding cassette transporter A1; ABCG1, ATP binding cassette transporter G1; ApoA-I, apolipoprotein A-I; CE, cholesteryl esters; HDL, high-density lipoprotein; PL, phospholipid; rHDL, reconstituted HDL; SUV, small unilamellar vesicles; and UC, unesterified cholesterol. more exposed (increased association constant) in the 7.6 nm particles, relative to the larger particles. This latter observation was somewhat surprising because the C-terminal segment of apoA-I has lipid-binding properties and its truncation reduces cholesterol efflux to lipid-free apoA-I. 26 Figure 3 shows ABCG1-specific efflux to individual discoidal rHDL particles. When matched for protein concentration ( Figure 3A ), efflux from all except the smallest (7.5 nm) rHDLs was similar to HDL2, whereas when normalized for phospholipid all rHDL particles were equally efficient ( Figure 3B ). Combined data from 3 separate discoidal rHDL purifications further explore this relationship (Online Figure III) . ABCG1-specific efflux was independent of phospholipid:protein ratio when the acceptors were normalized for phospholipid concentration (Online Figure IIIB) . A linear relationship between efflux and phospholipid:apoA-I ratio was observed for acceptors at matched protein concentrations (Online Figure IIIA) , which probably reflects the dependence of ABCG1-mediated efflux on the phospholipid content of the acceptor.
ABCA1-and ABCG1-Specific Cholesterol Efflux to Plasma HDL Fractions
The above experiments show that ABCA1 exports cholesterol efficiently to lipidated apoA-I present in particles not exceeding ≈8 nm in diameter and with a phospholipid:apoA-I ratio of <50:1. Plasma HDL is a heterogenous mixture of particles of varying size and composition, the smallest of which (HDL3b and HDL3c) fall within these parameters. 1 We considered that the robust ABCA1-specific cholesterol efflux mediated by HDL3 ( Figure 1 ) might depend largely on the activity of these HDL subfractions. We, therefore, compared the capacities of HDL2b, HDL2a, HDL3a, HDL3b, and HDL3c to mediate ABCA1-and ABCG1-specific cholesterol efflux. These subfractions have been extensively characterized previously, 1, 27 and the composition of the material used in this study is summarized in Online Table II . Surface plasmon resonance analysis of the binding affinities of epitope-specific antiapoA-I antibodies did not detect any major differences in apoA-I organization between the HDL3 subfractions although a general inverse trend was observed between binding affinity of most epitope-specific antibodies and particle size (Online Figure IVt) . The differences between subfractions were not so marked as for discoidal rHDLs, potentially reflecting the complex composition of plasma HDL fractions. 1, 28 Other apolipoproteins associated with plasma HDL may affect the flexibility of apoA-I; for example, apoA-II forms salt bridges with apoA-I and is likely to limit changes in its conformation. ]-cholesterol efflux from control and ABCA1-CHO cells was measured over 6 h with purified discoidal rHDL particles, apolipoprotein A-I (apoA-I) or HDL2. ABCA1-specific efflux was calculated as described in Methods. Data are means±SD (n=3), plotted against acceptor protein (A) or phospholipid (B) concentrations and fitted to the MichaelisMenten equation. Individual points in C and D are ABCA1-specific efflux measured over 6 h using purified particles at matched (10 μg/ mL) protein concentration (means of triplicate measurements) and are plotted against particle diameter (C) or phospholipid:apoA-I ratio (D). Data are collected from 3 separate particle preparations and are expressed relative to efflux to apoA-I in the same experiment. However, all HDL subfractions stimulated significantly faster efflux from ABCA1-expressing cells than from control cells. ABCA1-specific [ 3 H]-cholesterol efflux (calculated as the difference between the rates of efflux from ABCA1-CHO and control CHO cells; Figure 4B ) was inversely related to HDL fraction size, with efflux rates to the HDL3b and HDL3c fractions similar to that to lipid-free apoA-I. A similar trend was observed when the HDL fractions were presented at matched phospholipid concentrations (Online Figure V) .
Comparable measurements of ABCG1-dependent cholesterol efflux ( Figure 4C and 4D) showed a direct relationship between HDL particle size and efflux efficiency (at matched protein concentration), with larger HDL2 fractions being most efficient. This probably reflects the higher phospholipid:protein content of HDL2 because all subfractions mediated ABCG1-specific efflux equally efficiently when matched for phospholipid concentration (Online Figure  VC and VD), comparable with the results for discoidal rHDL species (Figure 3 ; Online Figure III) .
To exclude the possibility that lipid-free apoA-I was released during incubation of HDL with cells and was responsible for the ABCA1-specific efflux observed, we incubated HDL3b for 6 h at 37°C in culture medium alone or with either primary human macrophages or ABCA1-CHO cells. The samples were then subjected to nondenaturing gradient gel electrophoresis then blotted and probed for apoA-I ( Figure 5A ). None of the treatments showed detectable apoA-I migrating at the position of the lipid-free apolipoprotein. Furthermore, cholesterol efflux stimulated by untreated and ABCA1-CHO-pretreated HDL3b was identical ( Figure 5B ). Therefore it seems unlikely that substantial quantities of lipid-free apoA-I are generated during incubation of small HDL species with cells.
The higher ABCA1-specific efflux efficiency of smaller HDL fractions might reflect greater cell-surface binding. Binding of HDL subfractions to control and ABCA1-expressing CHO cells was therefore measured ( Figure 5C ). ABCA1 expression significantly increased binding of lipidfree apoA-I, HDL3b and HDL3c, but not of the larger HDL fractions. It has been suggested that surface binding of apoA-I is essential for ABCA1-dependent export of cellular cholesterol, 31 suggesting that the capacity of small HDL species for ABCA1-dependent cell surface binding may be related to their ability to promote cholesterol export.
Roles of Endogenous ABCA1 and ABCG1 in Cholesterol Efflux From Macrophages to HDL Species
To explore the roles of endogenously expressed ABCA1 and ABCG1 in cholesterol efflux to plasma HDL subfractions, we first compared efflux from bone marrow macrophages isolated from wild-type, ABCA1-null or ABCG1-null (Δ-ABCG1) mice. The macrophages were preloaded with both radiolabelled cholesterol and acetylated low-density lipoprotein and pretreated for 24 hours with an LXR ligand to maximize expression of ABCA1 and ABCG1. Importantly, expression of ABCA1 in ABCG1-null macrophages and of ABCG1 in ABCA1-null macrophages was identical to wild-type cells ( Figure 6A ).
ABCA1 deletion significantly reduced cholesterol efflux to all HDL fractions tested as well as to lipid-free apoA-I ( Figure 6B ). ABCA1-specific efflux (the difference between efflux from ABCA1-null and wild-type cells) is shown in Figure 6C . That ABCA1 in mouse macrophages contributes substantially to cholesterol efflux to HDL and lipid-free apoA-I is in agreement with our previous work. 12 As a percentage of total wild-type bone-marrow macrophages efflux, ABCA1 activity contributed >50% of total efflux to HDL3 and ≈ 90% of total efflux to HDL3b and HDL3c particles and a smaller and matched control cells. ABCA1-and ABCG1-specific cholesterol efflux rates were calculated as described in Methods and shown in B and D, respectively. All acceptors were supplied at 10 μg protein/ mL. Data are means±SD measured using HDL subfractions from 3 separate donors, each assayed in triplicate. *P<0.05 relative to matched control cell efflux.
(28.6±1.2%), but significant percentage of total cholesterol efflux to HDL2.
Efflux rates from wild-type and ABCG1-null macrophages are shown in Figure 6D and 6E. ABCG1 contributed a lesser proportion of total cholesterol efflux than ABCA1 to HDL. ABCG1-specific efflux was < 10% for all HDL populations, but was greatest for the larger HDL fractions (2b, 2a, and 3a) and negligible for HDL3b and 3c particles.
Cholesterol can move bidirectionally between cells and HDL by diffusional exchange, and the magnitude of this effect may vary between HDL subfractions, so we also measured net mass efflux of cholesterol (Online Figure VI) . Mass efflux rates were in some cases lower than those of [ . However, the ABCA1-and ABCG1-specific efflux rates measured by both mass and label efflux were similar. Overall, ABCA1 contributed the majority of cholesterol efflux to HDL and the smallest HDL particles were the most efficient acceptors.
We previously noted that cholesterol efflux from human macrophages to HDL was largely independent of ABCG1 expression, 18 but was partially ABCA1-dependent. For more detailed study of the capacity of human macrophage ABCA1 and ABCG1 to export cholesterol to individual HDL fractions we stably silenced expression of ABCA1 (Δ-ABCA1) or ABCG1 (Δ-ABCG1) in THP-1 cells ( Figure 7A ). Similar to mouse macrophages, cholesterol efflux from wild-type THP-1 cells was most strongly stimulated by HDL3b and HDL3c. ABCA1 silencing severely inhibited cholesterol efflux to lipid-free apoA-I ( Figure 7B and 7C) and also significantly reduced efflux to the smaller HDL fractions (3b and 3c) and whole HDL3. In contrast, ABCG1 silencing had a much lesser effect ( Figure 7D and 7E) and only efflux to HDL2b and whole HDL2 was significantly reduced (both P=0.04). Although the reduced efflux to HDL2 with ABCA1 silencing was not significant (Figure 7B) , it was numerically similar to the reduction with ABCG1 silencing (15.3±3.4% and 17.4±6.1% of wild-type, respectively). Overall, ABCA1 and ABCG1 contributed approximately equally to efflux stimulated by HDL2, whereas ABCA1 mediated the majority of efflux to HDL3 ( Figure 7C and 7E), indicating that ABCA1 is a more important mediator of cholesterol export from human macrophages than ABCG1, particularly to small, dense HDL fractions. This is consistent with the data from CHO cells stably expressing human ABCA1 and the effect of ABCA1 deletion in mouse macrophages.
To further confirm the importance of ABCA1 in cholesterol export to HDL, we measured cholesterol efflux from primary human monocyte-derived macrophages from normal donors and 3 Tangier subjects with loss-of-function ABCA1 mutations (detailed in Methods). ABCG1 protein expression was similar in all subjects and control cells ( Figure 7F ). As expected, cholesterol efflux to apoA-I was severely reduced in all Tangier subjects ( Figure 7G ). Efflux from control human monocyte-derived macrophages to individual HDL subfractions was similar to THP-1 macrophages, with HDL3b and HDL3c the most efficient and similar to lipid-free apoA-I. Because of the limited material available from Tangier donors, we were not able to test HDL2b. However, we established that loss of ABCA1 activity in primary human macrophages significantly reduced their ability to export cholesterol to HDL3b and HDL3c but had no effect on efflux to larger (HDL2a and 3a) particles. This further confirms the physiological significance of ABCA1 in cholesterol export to HDL and to lipidfree apoA-I.
Discussion
Understanding the determinants of HDL function is widely considered a critical priority in HDL research. Given the heterogeneity of HDL species in the circulation, understanding the transporters essential for cholesterol efflux and the HDL species, which are the major contributors to this process may direct contemporary strategies to optimize HDL function or deliver novel HDL analogues in vivo. The present study, which represents the most detailed evaluation of HDL particle size and cellular cholesterol efflux via ABCA1 and ABCG1 to date, has identified HDL size as a key determinant of the efflux capacity of HDL. We further demonstrate that ABCA1 is a quantitatively critical mediator of cholesterol efflux to HDL3, and that HDL3b, HDL3c and lipid-free apoA-I are all suitable therapeutic targets for optimizing cellular cholesterol efflux.
It is a widely held view that ABCA1 is an important mediator of cholesterol export and that it specifically requires apolipoproteins (such as apoA-I) that contain little or no lipid to stimulate its activity and to mediate removal of cellular cholesterol and phospholipid. 32 However, this is at odds with the low in vivo steady-state concentration of lipid-free/ lipid-poor apoA-I because the majority of this apoprotein is carried in a lipidated state as the major protein component of HDL. 1 There are also several reports that functional loss of ABCA1 activity is associated with a significant reduction in cholesterol efflux to HDL, and to lipid-free apoA-I including studies of fibroblasts and macrophages from subjects with Tangier disease, [16] [17] [18] ABCA1-null mouse macrophages 12, 33 and cell lines in which ABCA1 expression was silenced. 34 Conversely, stimulation of ABCA1 expression has been observed to increase cholesterol export to HDL and to lipid-free apoA-I. 8, 15 ABCA1-dependent cholesterol efflux to HDL is abolished by trypsin pretreatment, indicating that it involves HDL-associated apolipoproteins. 8 In the present study, we have made a more detailed study of the ability of ABCA1 to mediate cholesterol export to lipidated apoA-I, by examining a range of reconstituted and plasma HDL particles of varying size and lipid content. rHDL discs with a hydrodynamic diameter less than ≈8 nm and phospholipid:apoA-I ratio less than ≈50:1 were markedly better mediators of cell cholesterol export than larger particles. These data are consistent with another study, where ABCA1-dependent efflux from J774 mouse macrophages was efficiently promoted by 7.8 nm (40:1, phospholipid:apoA-I) but not by 9.6 nm (101:1, phospholipid:apoA-I) or larger rHDL discs. 13 Similarly, we showed that the smaller subfractions of human plasma HDL, HDL3b, and HDL3c, are highly efficient in ABCA1-specific efflux, in cells expressing human ABCA1 and in both mouse and human macrophages.
The mechanism by which HDL particles mediate ABCA1-dependent cholesterol efflux requires careful re-evaluation. One prevailing mechanism involves shedding of lipid-free apolipoproteins from HDL particles. 32 However, we could not find any evidence of apoA-I dissociation from HDL3b particles either alone or when incubated with cells. We cannot exclude the possibility that apoA-I is released from HDL and immediately lipidated by ABCA1-dependent mechanisms, leading to no net appearance of lipid-free apoA-I. Other studies have shown that apoA-I is not shed from 7.8 nm rHDL discs 13 or HDL species also containing apoA-II (as in plasma HDL3 species). 29 An alternative mechanism is that the ability of lipidated apoA-I to interact with ABCA1-expressing cells may depend on conformational constraints placed on the apolipoprotein through its lipid association, and that these constraints differ significantly between HDL subfractions. Consistent with this, we and others have shown that the percent helicity of apoA-I is less in HDL3b and 3c than in other HDL subfractions (61%-66% versus 76%) 35 and in small (7.8 nm) versus larger (9.6 nm) discoidal rHDLs (55%-59% versus 72%), 36 suggesting that some helical domains are unfolded in the smaller particles. Similarly, apoA-I is more sensitive to proteolysis in HDL3b and 3c versus larger HDL fractions and in small (7.8 nm) versus larger (12.5 nm) rHDLs. 35, 37 The antibody binding studies reported here and elsewhere 36 indicate that smaller rHDL discs have higher affinities for several epitope-specific antibodies against apoA-I than larger particles and a similar although less marked trend was observed between small and larger HDL subfractions, both here and elsewhere. 35 Overall the studies of helical content, protease sensitivity and, to a lesser extent, antibody binding, mentioned above indicate that conformational differences in apoA-I exist between small and larger rHDL discs and between small (HDL3b and 3c) particles compared with larger HDL species. We suggest that these differences may be the primary determinants of the capacity of lipidated apoA-I in small HDL particles to interact with ABCA1-expressing cells to mediate cholesterol export with efficiencies approaching that of lipid-free apoA-I. In addition, differences in the content of minor components (eg, phosphatidylserine) may contribute to the enhanced efflux capacity of small dense native HDL.
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ABCA1 expression and ABCA1-dependent efflux of cell cholesterol are closely associated with increased surface binding of apoA-I. 38 In the present study, we demonstrated ABCA1-dependent cellular binding of HDL3b and HDL3c but not of other 3 H]-cholesterol efflux from WT and Δ-ABCA1 THP-1 macrophages (B) or WT and Δ-ABCG1 THP-1 macrophages (D) to indicated acceptors (10 μg protein/mL) was measured for 6 h. The difference between efflux to WT and Δ-ABCA1 (C) or Δ-ABCG1 (E) cells are shown as transporter-specific efflux rates. Data are means±SD measured using HDL fractions from three separate donors, each assayed in triplicate; *P<0.05 relative to matched transporter-silenced cell. Human monocyte-derived macrophages from 3 Tangier subjects and normal (control) donors were isolated, differentiated and cholesterol-loaded as described in Methods. F, Western blot analysis (10 μg protein/lane). G, [ plasma HDL species, consistent with their superior efflux capacities. ABCA1-dependent surface binding of lipid-free apoA-I involves 2 distinct types of binding sites; saturable, high-affinity but low capacity direct binding to ABCA1 and a second highcapacity binding site. 31 Direct binding to ABCA1 contributes only ≈10% of total surface binding and is independent of N-or C-terminal deletions in apoA-I, suggesting that it is not specific and involves interaction of apoA-I amphipathic helices with the transporter. 31 The second site mediates the majority (≈90%) of apoA-I binding and is probably an ABCA1-dependent lipid domain, as removal of C-terminal lipid-binding domains of apoA-I strongly reduced binding to this site. It will be interesting to determine in future studies how HDL3b and HDL3c and small rHDLs interact with these distinct binding sites and particularly whether cell surface ABCA1-dependent lipid binding sites are accessible to the lipid-binding domain of apoA-I in these particles. Moreover, it will be instructive to determine whether these forms of lipidated apoA-I are able to protect ABCA1 from proteolytic degradation, as does lipid-free apoA-I.
We and others have previously shown that ABCG1 is promiscuous in its cholesterol acceptors, mediating efflux to low-density lipoprotein and phospholipid liposomes as well as HDL2 and HDL3. 10, 39, 40 Its expression does not promote HDL binding, but alters the disposition of cholesterol in the plasma membrane 22 and promotes cholesterol desorption and aqueous diffusion. 39 Our data on the relative efficiencies of different acceptors are entirely consistent with the only other detailed study of ABCG1 acceptor requirements, which used BHK cells expressing mifepristone-inducible ABCG1. 39 HDL-targeted therapies can have different effects on specific HDL subfractions 7, 14 and this could modulate the efficiency and mechanisms of cholesterol efflux. We have confirmed and extended earlier observations that ABCA1 mediates cholesterol efflux to HDL and have identified the HDL3 populations as the most active subfractions for this function. Macrophage ABCA1 contributes at least equally with ABCG1 in cholesterol export to HDL2 and mediates almost all HDL3-mediated efflux. As HDL3b and HDL3c particles are as efficient as lipid-free apoA-I in promoting ABCA1-mediated cholesterol efflux, and represent ≈20% to 25% of total plasma apoA-I, these particles are likely to be important effectors of cholesterol efflux and raise the novel suggestion that these should be considered as primary targets in HDL therapy. 
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What Is Known?
• High-density lipoprotein (HDL) stimulates export of excess cholesterol from cells.
• HDL is a heterogeneous mixture of particles of varying size and molecular composition.
• Cholesterol transporters ATP binding cassette transporter A1 (ABCA1) and ABCG1 can export cellular cholesterol to HDL. • ABCA1 is the major mediator of cholesterol export to apolipoprotein A-I.
What New Information Does This Article Contribute?
• Not all HDL particles participate equally in cellular cholesterol export.
The smallest HDL particles (HDL3b and HDL3c) are much more efficient than larger HDL particles.
• ABCA1 activity is essential for cholesterol export to HDL3b and HDL3c.
• ABCA1 is the major mediator of cholesterol export to HDL, not only to lipid-free apolipoprotein A-I.
• HDL-directed therapies should target increasing the concentration of small, dense HDL species.
Elevated HDL is associated with protection against cardiovascular disease and one of its many protective functions is the transport of excess cholesterol from peripheral cells to the liver. As HDL is a heterogenous mixture of particles, we hypothesized that some HDL particles might be more efficient in removal of cholesterol from cells than others. It is also not clear which membrane transporter(s) are most important for transfer of cellular cholesterol to HDL. In this article, we measured the capacity of individual subfractions of HDL particles to stimulate cholesterol export from cells and compared the activities of 2 major cholesterol transporters (ABCA1 and ABCG1) with these HDL fractions. We found large quantitative differences in the capacities of different HDL subfractions to remove cholesterol from cells, the smallest HDL particles being most efficient. We also showed that ABCA1 was the major mediator of cholesterol efflux to HDL, particularly to small HDL fractions. These finding suggest that HDL-directed therapies should specifically target increasing the concentrations, or the cholesterol efflux capacity, of small, dense HDL species in vivo. Authors Anatol Kontush and Kerry-Anne Rye should have been indicated as contributing equally to the article.
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Supplemental Figure Legends
Supplemental Figure I . Non-denaturing gradient gel electrophoresis of discoidal rHDL preparations A. Size analysis of rHDL disc mixtures prepared using initial phospholipid:apoA-I ratios of 50:1 and 100:1. B. Example of particles purified from rHDL disc preparations by size exclusion chromatography. Data are from a single experiment, representative of three separate preparations. In some cases the samples contained small amounts of adjacent particles, but this never exceeded 10% of total protein. Standard marker particle (Stds.) sizes (17-7.1 nm) are shown. The markers are thyroglobulin, ferritin, catalase, lactate dehydrogenase and albumin.
Supplemental Figure II . Physical characteristics of rHDL particles. A. Coomassie-stained NDGE of purified discoidal rHDLs. Molecular marker and particle sizes are indicated. B. SDS-PAGE of crosslinked apoA-I in purified discoidal rHDLs; crosslinked lipid-free apoA-I is shown for reference. For experiments shown in A. and B. samples were run on a single gel; dotted lines represent cropped lanes. C. Binding of apoA-I epitope-specific monoclonal antibodies to the same purified rHDLs. Numbers in parentheses indicate the inclusive amino acid residues of the epitope. Data are the calculated association rate constant ± SD for each antibody. ** P<0.005, * p<0.05.
Supplemental Figure III ABCG1-mediated efflux to defined rHDL particles ABCG1-specific efflux to rHDL particles generated in three separate particle preparations was measured over 6h as described in Figure 4 legend. Acceptors were used at either matched protein (10µg/ml; A.) or phospholipid (10µg/ml; B.) concentrations. To compensate for small variations in overall efflux rates between experiments, the data are given as a percentage of efflux to HDL2 in the same experiment. Each data point is the mean of triplicate measurements.
Supplemental Figure IV . Binding of apoA-I epitope-specific monoclonal antibodies to HDL subfractions Binding was measured by surface plasmon resonance as described in Methods. Data shown are the calculated association rate constant ± SD for each antibody. Numbers in parentheses next to each antibody indicate the inclusive amino acid residues of the epitope. Significant differences between pairs are indicated where present.
Supplemental Figure V . ABCA1-and ABCG1-dependent efflux to plasma HDL fractions (matched phospholipid concentration) Cholesterol efflux to HDL fractions from CHO cells stably expressing ABCA1 (A., B.) or ABCG1 (C., D.) and matched control cells. ABCA1-and ABCG1-specific cholesterol efflux rates were calculated as described in Methods and are shown in panels B and D, respectively. All HDL fractions were supplied at either 15µg phospholipid/ml (A,B) or 10µg phospholipid/ml (C,D). Lipid-free apoA-I was added at 10µg protein/ml. Data are means ± SD measured using HDL fractions from three separate donors, each assayed in triplicate. Key: * indicates significantly (p<0.05) different from corresponding control cell value.
Supplemental Figure VI . Mass cholesterol efflux to HDL fractions by primary mouse bone-marrowderived macrophages Cells and media from the experiments shown in Figure 8 were extracted and analysed by HPLC for cholesterol and cholesteryl ester content and cholesterol efflux calculated as described in Methods. All acceptors were supplied at 10µg protein/ml. Cholesterol efflux was measured from wild-type and Δ-ABCA1 macrophages (A.) or wild-type and Δ-ABCG1 macrophages (C.). The difference between efflux rates to WT and either Δ-ABCA1 (B.) or Δ-ABCG1 (D.) cells were used to calculate transporter-specific efflux rates. Data are means ± SD measured using HDL fractions from three separate donors, each assayed in triplicate. Key: * indicates efflux from WT cells is significantly (p<0.05) higher than matched knockout cells. 
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